دورية أكاديمية

[Detection rate and clinical characteristics of vulvar squamous intraepithelial lesion].

التفاصيل البيبلوغرافية
العنوان: [Detection rate and clinical characteristics of vulvar squamous intraepithelial lesion].
المؤلفون: Zhang L; Cervical Disease Center, Obstetrics and Gynecology Hospital of Fudan University, Shanghai 200011, China., Xiao YP; Department of Pathology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai 200011, China., Tao X; Department of Pathology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai 200011, China., Cao YK; Cervical Disease Center, Obstetrics and Gynecology Hospital of Fudan University, Shanghai 200011, China., Sui L; Cervical Disease Center, Obstetrics and Gynecology Hospital of Fudan University, Shanghai 200011, China., Cong Q; Cervical Disease Center, Obstetrics and Gynecology Hospital of Fudan University, Shanghai 200011, China.
المصدر: Zhonghua fu chan ke za zhi [Zhonghua Fu Chan Ke Za Zhi] 2023 Aug 25; Vol. 58 (8), pp. 603-610.
نوع المنشور: English Abstract; Journal Article
اللغة: Chinese
بيانات الدورية: Publisher: Chinese Medical Association Country of Publication: China NLM ID: 16210370R Publication Model: Print Cited Medium: Print ISSN: 0529-567X (Print) Linking ISSN: 0529567X NLM ISO Abbreviation: Zhonghua Fu Chan Ke Za Zhi Subsets: MEDLINE
أسماء مطبوعة: Publication: Peking : Chinese Medical Association
Original Publication: Beiping [1953?]-
مواضيع طبية MeSH: Papillomavirus Infections*/diagnosis , Papillomavirus Infections*/epidemiology , Vulvar Neoplasms*/diagnosis , Carcinoma in Situ*, Pregnancy ; Humans ; Female ; Retrospective Studies
مستخلص: Objective: To explore the detection rate, clinical characteristics of vulvar squamous intraepithelial lesion (SIL). Methods: Women diagnosed with vulvar high-grade squamous intraepithelial lesions (HSIL) through colposcopy-guided biopsy from January 1, 2018 to August 31, 2022 in Obstetrics and Gynecology Hospital of Fudan University were included in a 1∶1 ratio with patients diagnosed with vulvar low-grade squamous intraepithelial lesions (LSIL) during the same period. Clinical characteristics including human papillomavirus (HPV) infection rate, genotype, cytology result, colposcopy impression, and lesion location were retrospectively analyzed. Results: (1) The proportion of vulvar SIL detected by colposcopy-guided biopsy increased annually from 2018 to 2022, with rates of 1.64% (740/45 057), 2.34% (1 110/47 402), 2.68% (1 108/41 335), 3.26% (1 536/47 078), 3.31% (667/20 155), with an average rate of 2.57% (5 161/201 027). (2) A total of 1 096 cases of vulvar HSIL and 1 096 cases of vulvar LSIL were included. The overall infection rate of HPV was 92.7% (1 993/2 150), with higher infection rate in vulvar HSIL patients than that in vulvar LSIL patients [96.0% (1 012/1 054) vs 89.5% (981/1 096); χ 2 =33.62, P <0.001]. Among vulvar HSIL patients, the common HPV genotype from high to low were HPV 16 (66.7%), HPV 52 (14.3%), and HPV 58 (10.0%). For vulvar LSIL patients, the most common HPV genotype were respectively HPV 16 (24.9%), HPV 6 (20.1%) and HPV 52 (17.1%). The overall sensitivity rate of cytology was 53.6%, with no significance difference between vulvar LSIL and HSIL groups (54.3% vs 52.9%; χ 2 =0.40, P =0.526). The accuracy of colposcopy impression for vulvar HSIL was lower than that for vulvar LSIL [40.2% (163/405) vs 81.7% (380/465); χ 2 =158.72, P <0.001]. About 57.3% (1 257/2 192) of the patients had concomitant cervical and vaginal lesions, with a higher rate in vulvar HSIL group than that in vulvar LSIL group [62.6% (686/1 096) vs 52.1% (571/1 096); χ 2 =24.67, P <0.001]. Unifocal lesion was the main type, with no significance difference between vulvar LSIL and HSIL groups [81.4% (381/468) vs 82.5% (386/468); χ 2 =0.18, P =0.671]. The most common lesion locations were the posterior commissure, followed by labia minora, vaginal vestibule, labia majora, perianal and clitoris. Conclusions: The detection rate of vulvar SIL under colposcopy is about 3%, and the infection rate of HPV is 92.7%. Vulvar SIL, especially vulvar HSIL, is likely to cause concomitant cervical and vaginal lesions. The accuracy of colposcopy in diagnosing vulvar HSIL is low. Therefore a comprehensive and careful examination of the vulva is necessary and suspicious vulvar lesions should be undergone colposcopy-guided biopsy for diagnosis.
معلومات مُعتمدة: 202240079 Research Project of Shanghai Municipal Health Commission
فهرسة مساهمة: Local Abstract: [Publisher, Chinese] 目的: 探讨外阴鳞状上皮内病变(SIL)的检出率及临床特征。 方法: 收集2018年1月1日至2022年8月31日在复旦大学附属妇产科医院经阴道镜活检诊断为外阴高级别鳞状上皮内病变(HSIL)的患者(外阴HSIL组),按1∶1纳入同期病理诊断为外阴低级别鳞状上皮内病变(LSIL)的患者(外阴LSIL组)。回顾性分析外阴SIL的检出率,并比较两组患者人乳头状瘤病毒(HPV)的阳性率及亚型分布、细胞学检查结果、阴道镜诊断、病变部位等临床特征。 结果: (1)2018—2022年阴道镜引导下活检外阴SIL的检出率逐年升高,分别为1.64%(740/45 057)、2.34%(1 110/47 402)、2.68%(1 108/41 335)、3.26%(1 536/47 078)、3.31%(667/20 155),平均检出率为2.57%(5 161/201 027)。(2)本研究纳入外阴HSIL组患者1 096例,外阴LSIL组按1∶1纳入同期患者1 096例。2 192例外阴SIL患者中,2 150例有HPV检测结果,总HPV阳性率为92.7%(1 993/2 150),其中外阴HSIL组患者HPV阳性率显著高于外阴LSIL组[分别为96.0%(1 012/1 054)、89.5%(981/1 096); χ 2 =33.62, P <0.001];外阴HSIL组患者中最常见的HPV感染亚型自高到低依次为HPV 16型(66.7%)、HPV 52型(14.3%)和HPV 58型(10.0%),外阴LSIL组患者依次为HPV 16型(24.9%)、HPV 6型(20.1%)、HPV 52型(17.1%)。2 171例外阴SIL患者有子宫颈或阴道细胞学检查结果,细胞学检查的总体敏感度为53.6%,外阴LSIL组与外阴HSIL组分别为54.3%和52.9%,两组比较,差异无统计学意义( χ 2 =0.40, P =0.526)。870例外阴SIL患者有阴道镜诊断结果,外阴HSIL组阴道镜诊断的准确率显著低于外阴LSIL组[分别为40.2%(163/405)、81.7%(380/465); χ 2 =158.72, P <0.001]。2 192例外阴SIL患者中,合并子宫颈阴道病变者占57.3%(1 257/2 192);其中,外阴HSIL组患者合并子宫颈阴道病变的发生率显著高于外阴LSIL组[分别为62.6%(686/1 096)和52.1%(571/1 096); χ 2 =24.67, P <0.001]。936例有病灶数统计资料的外阴SIL患者中,外阴HSIL组中82.5%(386/468)的患者为单个病灶,外阴LSIL组为81.4%(381/468),两组比较,差异无统计学意义( χ 2 =0.18, P =0.671);936例有病灶部位统计资料的外阴SIL患者中,外阴SIL病灶的好发部位为后联合(67.4%,631/936),其次依次为小阴唇、阴道前庭、大阴唇、肛周和阴蒂。 结论: 阴道镜活检外阴SIL的检出率约为3%,其HPV阳性率为92.7%。外阴SIL尤其是外阴HSIL易合并子宫颈阴道病变,而阴道镜诊断外阴HSIL的准确率低,易出现诊断不足,因此,须对外阴各部位进行全面仔细观察,对可疑部位进行活检以明确诊断。.
SCR Organism: human papillomavirus 52; human papillomavirus 58
تواريخ الأحداث: Date Created: 20230820 Date Completed: 20230822 Latest Revision: 20230822
رمز التحديث: 20231215
DOI: 10.3760/cma.j.cn112141-20230607-00255
PMID: 37599258
قاعدة البيانات: MEDLINE